Evidence map›Paper›PMID 30461363›Full record

ArticleJournal of neurophysiology2019

An investigation into the noradrenergic and serotonergic contributions of diffuse noxious inhibitory controls in a monoiodoacetate model of osteoarthritis.

S M Lockwood, K Bannister, A H Dickenson

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurophysiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

S M LockwoodDepartment of Neuroscience, Physiology and Pharmacology, University College London , London , United Kingdom.
K BannisterWolfson CARD, Hodgkin Building, Kings College London , London , United Kingdom.
A H DickensonDepartment of Neuroscience, Physiology and Pharmacology, University College London , London , United Kingdom.
University College London · GBKing's College London · GB

Funding

Wellcome Trust 102645
6 · The paper itself

Abstract

Osteoarthritis (OA) is a debilitating conditioning with pain as the major clinical symptom. Understanding the mechanisms that drive OA-associated chronic pain is crucial for developing the most effective analgesics. Although the degradation of the joint is the initial trigger for the development of chronic pain, the discordance between radiographic joint damage and the reported pain experience in patients, coupled with clinical features that cannot be explained by purely peripheral mechanisms, suggest there are often other factors at play. Therefore, this study considers the central contributions of chronic pain, using a monoiodoacetate (MIA) model of OA. Particularly, this study explores the functionality of descending controls over the course of the model by assessing diffuse noxious inhibitory controls (DNIC). Early-phase MIA animals have a functional DNIC system, whereas DNIC are abolished in late-phase MIA animals, indicating a dysregulation in descending modulation over the course of the model. In early-phase animals, blocking the actions of spinal α

Indexed as

Action PotentialsAdrenergic alpha-2 Receptor AntagonistsAnimalsDiffuse Noxious Inhibitory ControlDisease Models, AnimalDisease ProgressionGanglia, SpinalIodoacetic AcidMaleNeural InhibitionNeuronsNorepinephrineOsteoarthritisRats, Sprague-DawleyReceptors, Adrenergic, alpha-2Receptors, SerotoninAdrenergic alpha-2 Receptor AntagonistsIodoacetic AcidNorepinephrineReceptors, Adrenergic, alpha-2Receptors, SerotoninRNA, MessengerSerotoninserotonin 7 receptorSerotonin Antagonistsdescending modulationdiffuse noxious inhibitory controlsnorepinephrineserotonin

Identifiers

PMID30461363
PMCPMC6383660
OpenAlexW2901968415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.